Rezultati - Michael Schepke
- Showing 1 - 7 results of 7
-
1
-
2
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase od Jonel Trebicka, Martin Hennenberg, Wim Laleman, Nataliya Shelest, Erwin Biecker, Michael Schepke, Frederik Nevens, Tilman Sauerbruch, Jörg Heller
Izdano 2007Artigo -
3
-
4
-
5
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension od Michael Schepke, Eva Penelo, Erwin Biecker, Peter Schiedermaier, J. Heller, Markus Neef, Wolfgang H. Caselmann, T. Sauerbruch, Birgit Stoffel‐Wagner, U. Hofer
Izdano 2001Artigo -
6
Higher Adenoma Detection Rates with Endocuff-Assisted Colonoscopy – A Randomized Controlled Multicenter Trial od Martin Floer, Erwin Biecker, Rüdiger Fitzlaff, Hermann Röming, Detlev Ameis, Achim Heinecke, Steffen Kunsch, Volker Ellenrieder, Philipp Ströbel, Michael Schepke, Tobias Meister
Izdano 2014Artigo -
7
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy od Tilman Sauerbruch, Martin Mengel, Matthias Dollinger, Alexander Zipprich, Martin Rössle, Elisabeth Panther, Reiner Wiest, Karel Caca, Albrecht Hoffmeister, Holger H. Lutz, Rüdiger Schoo, Henning Lorenzen, Jonel Trebicka, Beate Appenrodt, Michael Schepke, Rolf Fimmers
Izdano 2015Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cirrhosis
Portal hypertension
Surgery
Chemistry
Endocrinology
Gastroenterology
Portal venous pressure
Randomized controlled trial
Receptor
Adenoma
Adverse effect
Airway
Angiotensin II
Angiotensin II receptor antagonist
Angiotensin II receptor type 1
Angiotensin receptor
Antagonist
Atorvastatin
Biochemistry
Biology
Blood pressure
Calcium
Cancer
Cardiology
Chemotherapy
Clinical endpoint
Colonoscopy
Colorectal adenoma